Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor ImmunityCancer discovery, 2017-05, Vol.7 (5), p.522-538ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.CD-16-0932Full text available |
|
2 |
Material Type: Article
|
Novel Anti-LY6G6D/CD3 T-Cell–Dependent Bispecific Antibody for the Treatment of Colorectal CancerMolecular cancer therapeutics, 2022-04, Vol.21 (6) [Peer Reviewed Journal]ISSN: 1535-7163 ;EISSN: 1538-8514Full text available |
|
3 |
Material Type: Book
|
CT Colonography for Radiographers: A Guide to Performance and Image InterpretationISBN: 9783319293776 ;ISBN: 331929377X ;EISBN: 9783319293790 ;EISBN: 3319293796 ;OCLC: 957699992Full text available |
|
4 |
Material Type: Article
|
Patient-Reported Outcomes in Pediatric Cancer Registration Trials: A US Food and Drug Administration PerspectiveJNCI : Journal of the National Cancer Institute, 2021-04, Vol.114 (1) [Peer Reviewed Journal]ISSN: 0027-8874 ;EISSN: 1460-2105Full text available |
|
5 |
Material Type: Article
|
Translating Evidence from Dutch Exercise Oncology Trials in Patients with Breast Cancer into Clinical Practice Using the RE-AIM Frameworkinfo:eu-repo/semantics/OpenAccess ;ISSN: 0961-5423 ;EISSN: 1365-2354Full text available |
|
6 |
Material Type: Article
|
Retraction: Effects of Aidi injection on life quality and incidence of adverse reactions in patients with non-small cell lung cancer compared with traditional chemotherapy: a systematic review and meta-analysisFrontiers in oncology, 2024, Vol.14, p.1383346-1383346 [Peer Reviewed Journal]Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383346 ;PMID: 38440226Full text available |
|
7 |
Material Type: Article
|
Retraction: Meta analysis of clinical prognosis of radiofrequency ablation versus partial nephrectomy in the treatment of early renal cell carcinomaFrontiers in oncology, 2024, Vol.14, p.1383353-1383353 [Peer Reviewed Journal]Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383353 ;PMID: 38444681Full text available |
|
8 |
Material Type: Article
|
Retraction: The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancerFrontiers in oncology, 2024, Vol.14, p.1383383-1383383 [Peer Reviewed Journal]Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383383 ;PMID: 38450197Full text available |
|
9 |
Material Type: Article
|
Retraction: Evaluation of the safety of retroperitoneal laparoscopic partial nephrectomy by investigating the perioperative indicatorsFrontiers in oncology, 2024, Vol.14, p.1383340-1383340 [Peer Reviewed Journal]Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383340 ;PMID: 38440232Full text available |
|
10 |
Material Type: Article
|
Retraction: Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysisFrontiers in oncology, 2024, Vol.14, p.1383366-1383366 [Peer Reviewed Journal]Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383366 ;PMID: 38440228Full text available |
|
11 |
Material Type: Article
|
Retraction: Establishment of criteria for molecular differential diagnosis of MPC and IPMFrontiers in oncology, 2024, Vol.14, p.1399853-1399853 [Peer Reviewed Journal]Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1399853 ;PMID: 38577339Full text available |
|
12 |
Material Type: Article
|
Retraction: Overexpressed tumor suppressor exosomal miR-15a-5p in cancer cells inhibits PD1 expression in CD8+T cells and suppresses the hepatocellular carcinoma progressionFrontiers in oncology, 2024, Vol.14, p.1388383-1388383 [Peer Reviewed Journal]Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1388383 ;PMID: 38505586Full text available |
|
13 |
Material Type: Article
|
Retraction: A study on expression level and nutritional status of IGFBP-2 after left neck anastomosis combined with placement of feeding nutritional applicators carrying ^(125)I particles in the treatment of esophageal cancerFrontiers in oncology, 2024, Vol.14, p.1383394-1383394 [Peer Reviewed Journal]Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383394 ;PMID: 38450196Full text available |
|
14 |
Material Type: Article
|
Retraction: The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: a retrospective analysisFrontiers in oncology, 2024, Vol.14, p.1383410-1383410 [Peer Reviewed Journal]Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383410 ;PMID: 38444679Full text available |
|
15 |
Material Type: Article
|
Retraction: A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinomaFrontiers in oncology, 2024, Vol.14, p.1383375-1383375 [Peer Reviewed Journal]Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383375 ;PMID: 38454926Full text available |
|
16 |
Material Type: Article
|
Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicinFrontiers in oncology, 2023-12, Vol.13, p.1337635-1337635 [Peer Reviewed Journal]Copyright © 2023 Frontiers Editorial Office. ;Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1337635 ;PMID: 38130993Full text available |
|
17 |
Material Type: Article
|
Retraction: New insights into molecular signalling pathways and current advancements in prostate cancer diagnostics and therapeuticsFrontiers in oncology, 2023-12, Vol.13, p.1343833-1343833 [Peer Reviewed Journal]Copyright © 2023 Frontiers Editorial Office. ;Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1343833 ;PMID: 38130994Full text available |
|
18 |
Material Type: Article
|
Retraction: Long noncoding RNA LOC400043 (LINC02381) inhibits gastric cancer progression through regulating Wnt signaling pathwayFrontiers in oncology, 2023-12, Vol.13, p.1298859-1298859 [Peer Reviewed Journal]Copyright © 2023 Frontiers Editorial Office. ;Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1298859 ;PMID: 38115901Full text available |
|
19 |
Material Type: Article
|
Retraction: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumorsFrontiers in oncology, 2023-10, Vol.13, p.1301668-1301668 [Peer Reviewed Journal]Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1301668Full text available |
|
20 |
Material Type: Article
|
Retraction: LncRNA TCF7 promotes epithelial ovarian cancer viability, mobility and stemness via regulating ITGB8Frontiers in oncology, 2023-10, Vol.13, p.1307324-1307324 [Peer Reviewed Journal]Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1307324Full text available |